Status: current, Defined. Date: 31-Mar 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4542951000168112 | glycopyrronium 46 microgram + indacaterol 114 microgram + mometasone furoate 136 microgram powder for inhalation, capsule (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4542961000168114 | indacaterol 114 microgram + glycopyrronium 46 microgram + mometasone furoate 136 microgram powder for inhalation, capsule | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| indacaterol 114 microgram + glycopyrronium 46 microgram + mometasone furoate 136 microgram powder for inhalation, capsule | Is a | indacaterol + glycopyrronium + mometasone | true | Inferred relationship | Some | ||
| indacaterol 114 microgram + glycopyrronium 46 microgram + mometasone furoate 136 microgram powder for inhalation, capsule | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| indacaterol 114 microgram + glycopyrronium 46 microgram + mometasone furoate 136 microgram powder for inhalation, capsule | has manufactured dose form | powder for inhalation | true | Inferred relationship | Some | ||
| indacaterol 114 microgram + glycopyrronium 46 microgram + mometasone furoate 136 microgram powder for inhalation, capsule | has unit of use | capsule | true | Inferred relationship | Some | 138993917 | |
| indacaterol 114 microgram + glycopyrronium 46 microgram + mometasone furoate 136 microgram powder for inhalation, capsule | has Australian BoSS | glycopyrronium | true | Inferred relationship | Some | 1788098726 | |
| indacaterol 114 microgram + glycopyrronium 46 microgram + mometasone furoate 136 microgram powder for inhalation, capsule | has intended active ingredient | glycopyrronium | true | Inferred relationship | Some | 1788098726 | |
| indacaterol 114 microgram + glycopyrronium 46 microgram + mometasone furoate 136 microgram powder for inhalation, capsule | has intended active ingredient | mometasone | true | Inferred relationship | Some | 1608549241 | |
| indacaterol 114 microgram + glycopyrronium 46 microgram + mometasone furoate 136 microgram powder for inhalation, capsule | has Australian BoSS | mometasone furoate | true | Inferred relationship | Some | 1608549241 | |
| indacaterol 114 microgram + glycopyrronium 46 microgram + mometasone furoate 136 microgram powder for inhalation, capsule | has intended active ingredient | indacaterol | true | Inferred relationship | Some | 1236147072 | |
| indacaterol 114 microgram + glycopyrronium 46 microgram + mometasone furoate 136 microgram powder for inhalation, capsule | has Australian BoSS | indacaterol | true | Inferred relationship | Some | 1236147072 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Enerzair Breezhaler 114/46/136 powder for inhalation, capsule | Is a | True | indacaterol 114 microgram + glycopyrronium 46 microgram + mometasone furoate 136 microgram powder for inhalation, capsule | Inferred relationship | Some | |
| indacaterol 114 microgram + glycopyrronium 46 microgram + mometasone furoate 136 microgram powder for inhalation, 30 capsules | has MPUU | True | indacaterol 114 microgram + glycopyrronium 46 microgram + mometasone furoate 136 microgram powder for inhalation, capsule | Inferred relationship | Some | 729829237 |
| indacaterol 114 microgram + glycopyrronium 46 microgram + mometasone furoate 136 microgram powder for inhalation, 10 capsules | has MPUU | True | indacaterol 114 microgram + glycopyrronium 46 microgram + mometasone furoate 136 microgram powder for inhalation, capsule | Inferred relationship | Some | 1599736604 |
Reference Sets
Medicinal product unit of use reference set
FHIR